EZRA_STAA1
ID EZRA_STAA1 Reviewed; 564 AA.
AC A7X3E7;
DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT 23-OCT-2007, sequence version 1.
DT 25-MAY-2022, entry version 79.
DE RecName: Full=Septation ring formation regulator EzrA {ECO:0000255|HAMAP-Rule:MF_00728};
GN Name=ezrA {ECO:0000255|HAMAP-Rule:MF_00728}; OrderedLocusNames=SAHV_1703;
OS Staphylococcus aureus (strain Mu3 / ATCC 700698).
OC Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC Staphylococcus.
OX NCBI_TaxID=418127;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Mu3 / ATCC 700698;
RX PubMed=17954695; DOI=10.1128/aac.00534-07;
RA Neoh H.-M., Cui L., Yuzawa H., Takeuchi F., Matsuo M., Hiramatsu K.;
RT "Mutated response regulator graR is responsible for phenotypic conversion
RT of Staphylococcus aureus from heterogeneous vancomycin-intermediate
RT resistance to vancomycin-intermediate resistance.";
RL Antimicrob. Agents Chemother. 52:45-53(2008).
CC -!- FUNCTION: Negative regulator of FtsZ ring formation; modulates the
CC frequency and position of FtsZ ring formation. Inhibits FtsZ ring
CC formation at polar sites. Interacts either with FtsZ or with one of its
CC binding partners to promote depolymerization. {ECO:0000255|HAMAP-
CC Rule:MF_00728}.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255|HAMAP-Rule:MF_00728};
CC Single-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_00728}.
CC Note=Colocalized with FtsZ to the nascent septal site.
CC {ECO:0000255|HAMAP-Rule:MF_00728}.
CC -!- SIMILARITY: Belongs to the EzrA family. {ECO:0000255|HAMAP-
CC Rule:MF_00728}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AP009324; BAF78586.1; -; Genomic_DNA.
DR RefSeq; WP_000244866.1; NC_009782.1.
DR PDB; 4UY3; X-ray; 2.60 A; A=24-214.
DR PDBsum; 4UY3; -.
DR AlphaFoldDB; A7X3E7; -.
DR SMR; A7X3E7; -.
DR KEGG; saw:SAHV_1703; -.
DR HOGENOM; CLU_034079_1_0_9; -.
DR OMA; FRSQNHI; -.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR GO; GO:0005940; C:septin ring; IEA:InterPro.
DR GO; GO:0000917; P:division septum assembly; IEA:UniProtKB-KW.
DR GO; GO:0000921; P:septin ring assembly; IEA:InterPro.
DR HAMAP; MF_00728; EzrA; 1.
DR InterPro; IPR010379; EzrA.
DR Pfam; PF06160; EzrA; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Cell cycle; Cell division; Cell membrane; Coiled coil;
KW Membrane; Septation; Transmembrane; Transmembrane helix.
FT CHAIN 1..564
FT /note="Septation ring formation regulator EzrA"
FT /id="PRO_1000045901"
FT TOPO_DOM 1..4
FT /note="Extracellular"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00728"
FT TRANSMEM 5..23
FT /note="Helical"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00728"
FT TOPO_DOM 24..564
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00728"
FT COILED 99..138
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00728"
FT COILED 190..223
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00728"
FT COILED 271..300
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00728"
FT COILED 350..435
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00728"
FT COILED 471..550
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00728"
FT HELIX 24..41
FT /evidence="ECO:0007829|PDB:4UY3"
FT HELIX 46..54
FT /evidence="ECO:0007829|PDB:4UY3"
FT HELIX 60..80
FT /evidence="ECO:0007829|PDB:4UY3"
FT TURN 81..83
FT /evidence="ECO:0007829|PDB:4UY3"
FT HELIX 84..96
FT /evidence="ECO:0007829|PDB:4UY3"
FT HELIX 100..158
FT /evidence="ECO:0007829|PDB:4UY3"
FT HELIX 161..166
FT /evidence="ECO:0007829|PDB:4UY3"
FT HELIX 167..175
FT /evidence="ECO:0007829|PDB:4UY3"
FT HELIX 177..189
FT /evidence="ECO:0007829|PDB:4UY3"
FT HELIX 193..213
FT /evidence="ECO:0007829|PDB:4UY3"
SQ SEQUENCE 564 AA; 66228 MW; 4DE5BC809CCE7489 CRC64;
MVLYIILAII VIILIAVGVL FYLRSNKRQI IEKAIERKNE IETLPFDQNL AQLSKLNLKG
ETKTKYDAMK KDNVESTNKY LAPVEEKIHN AEALLDKFSF NASQSEIDDA NELMDSYEQS
YQQQLEDVNE IIALYKDNDE LYDKCKVDYR EMKRDVLANR HQFGEAASLL ETEIEKFEPR
LEQYEVLKAD GNYVQAHNHI AALNEQMKQL RSYMEEIPEL IRETQKELPG QFQDLKYGCR
DLKVEGYDLD HVKVDSTLQS LKTELSFVEP LISRLELEEA NDKLANINDK LDDMYDLIEH
EVKAKNDVEE TKDIITDNLF KAKDMNYTLQ TEIEYVRENY YINESDAQSV RQFENEIQSL
ISVYDDILKE MSKSAVRYSE VQDNLQYLED HVTVINDKQE KLQNHLIQLR EDEAEAEDNL
LRVQSKKEEV YRRLLASNLT SVPERFIIMK NEIDHEVRDV NEQFSERPIH VKQLKDKVSK
IVIQMNTFED EANDVLVNAV YAEKLIQYGN RYRKDYSNVD KSLNEAERLF KNNRYKRAIE
IAEQVLESVE PGVTKHIEEE VIKQ